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Abstract
A currently used intensity-modulated radiotherapy system is the TomoTherapy® Hi-Art®
accelerator (Tomotherapy Inc., Madison, WI, USA), which started clinical treatments at the
beginning of the new millennium. The innovative idea behind tomotherapy units is to marry an
x-ray computed tomography unit with a linear particle accelerator. This concept has answered
some of the needs of the medical physicist community, but epidemiological evaluations are still
needed in order to compare the technique with other modalities. This paper summarizes the
basic concepts of tomotherapy units as well as current challenges and implications for users.
(Some figures in this article are in colour only in the electronic version)
This article was invited by G Gillies.
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1. Introduction
This paper focuses on TomoTherapy® Hi-Art® (Tomotherapy
Inc., Madison, WI, USA) accelerators, referred to hereinafter
simply as tomotherapy units, and their inherent challenges for
medical physicists. Furthermore, we do not want to go into
the details of the history of radiotherapy in general, especially
when standard medical physics textbooks and comprehensive
review papers are plentiful, e.g. Karzmark (1984), Meredith
(1984), Van Dyk (1999), Thwaites and Tuohy (2006), S Balter
and J Balter (2008), Hannoun-Levi et al (2010). However,
we will provide a brief historical overview in order to put
tomotherapy into its historical context. This paper is not
intended for radiotherapy experts and will not go deeply into
technical details, but we do intend the references to offer many
points of content expansion for keen readers.
Radiotherapy is an essential element in the treatment of
cancer patients; it is used alone or in combination with surgery
or chemotherapy, and it has become a well-recognized curative
and palliative therapy. Because of localization uncertainties,
a margin of normal tissue around the tumour is included in
the treatment region. These uncertainties can be caused by
natural movements, such as respiration or bladder filling, or by
displacement of the tumour in relationship to external markers.
The holy grail of radiotherapy is to be able to deliver a lethal
dose of radiation to tumours while simultaneously preserving
normal tissue, thus radically eliminating cancer cells with the
lowest possible treatment toxicity, which implies minimizing
margins.
In radiotherapy, the total treatment dose is delivered
over time in fractions. This concept was developed out of
necessity, because of limitations of the first radiotherapy units.
Nowadays, biological reasons justify fractionation. Indeed,
tumour cells have a typically less efficient repair mechanism,
which allows healthy cells to recover relatively better between
fractions. Furthermore, tumour cells in a radio-resistant phase
are expected to enter a more radio-sensitive phase for the next
fraction.
Historically, the last decade of the 19th century is
where radiotherapy has its origins. In 1895, W C Ro¨ntgen
discovered x-rays, and one year later, H Becquerel reported
on natural radioactivity. In 1898, Pierre and Marie Curie
discovered radium. Shortly after these discoveries, therapy
using radiation was already proposed. In February 1896
in Chicago, E H Grubbe founded the first radiation therapy
facility. Anecdotally, he died in 1960 at the respectable age of
85, and is reported as the first person to have been injured by
radiation.
Early on in the evolution of radiotherapy, the advantages of
higher energy radiation were recognized. However, technical
barriers did not permit megavoltage accelerators until the
1930s. Historical accounts see this period as the passage of
radiotherapy from palliative to curative. Indeed, the following
decades saw radiotherapy moving from a qualitative technique
performed by a handful of talented experts to a quantitative
therapy allowing treatment to be carried out on a larger
scale.
The 1950s saw the first linear particle accelerators
(LINACs) dedicated to radiotherapy operational in England
and the United States. The evolution thereafter was
remarkable, in the 1960s less than 20 LINACs were in use
in few privileged countries; in the 1980s nearly 80 were
running and nowadays there are thousands worldwide. The
LINAC became simultaneously the radiotherapy instrument
of choice over van de Graafs, betatrons and Co-60 irradiators.
Its beginnings were modest and technological advances have
permitted the LINAC to impose itself since the 1970s with an
overall design which is still currently in use.
In the 1970s, the invention and subsequent medical use of
the x-ray computed tomography (CT) led to 2D radiotherapy,
and 20 years later, advances in computer technology made
3D conformal radiotherapy possible. Currently, image-guided
radiation therapy (IGRT) refers to many techniques, which
apply various types of imaging in order to control patient
positioning (Huq et al 2008, Verellen et al 2008, Alongi and
Di Muzio 2009, Korreman et al 2010).
Finally, in the 2000s, intensity-modulated radiotherapy
(IMRT) became a major technology. In the future, the
clinical introduction of imaging techniques with better soft
tissue contrast or functional capacities, such as magnetic
resonance imaging and positron emission tomography, is the
logical step for IGRT systems. Recently, the technology
of integrating imaging techniques, such as cone-beam-CT
(CBCT), has reached clinical application. Currently in IMRT
and radiotherapy in general, much effort is being invested to
improve the conformity of dose distribution as well as using
tumour tracking schemes.
Before the acceptance and widespread use of IMRT, in
the late 1980s, the technique that would become known as
tomotherapy was being shaped at the University of Wisconsin.
A thorough history of the birth and early years of the technique
was written by one of its designers, Mackie (2006), and some
milestones are summarized in figure 1. The very first paper
on tomotherapy was published in 1993 (Mackie et al 1993).
The development of tomotherapy at the physical laboratory of
the University of Wisconsin was supported through federal
funding and General Electric Medical Systems until 1997.
In 1997, under financial pressure, TomoTherapy Inc. was
founded to pursue the development of the clinical helical
tomotherapy prototype. In 2001, the first clinical unit was
completed and in 2002, the first human patient was treated at
the University of Wisconsin. We will provide further details
on some of the particularities of tomotherapy design, but in
short, this treatment unit is basically a CT with an LINAC that
replaces the x-ray tube.
The idea of a conventional multileaf collimator (MLC)
used to modulate the field intensity was in the air in the
1990s, and other concepts were developed at the same time
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Figure 1. Major milestones leading to tomotherapy accelerators.
(Convery and Rosenbloom 1992, Carol 1995) which attained
varying levels of commercial success. Carol’s system was
a success and the first patients were treated in 1994. The
company changed its name to Nomos Corporation (Nomos
Corporation, Swickley, PA, USA) and started selling the
Peacock™ in 1996. The treatment was described as serial
tomotherapy, since it is delivered by a number of discrete arcs
between which the treatment couch is moved. The Peacock™
uses an MLC, which can be added to an existing LINAC unit
and clinics starting out with IMRT could upgrade instead of
investing in a totally new accelerator.
The current commercial competitors for the title of the
future of IMRT are based on the intensity-modulated arc
therapy system (IMAT) first proposed by Yu (1995). The
IMAT concept makes use of MLC-shaped fields, which
define the intensity distribution at each angle (Yu 1995).
In comparison with tomotherapy units, IMAT units do
not deliver the dose using a slit or fan beam, which is
fundamentally different because the dose is delivered in a
single rotation. Another benefit is that IMAT relies on a
concept applicable to conventional LINACs. However, IMAT
did not achieve commercial success despite its promising
potential, and later developments led to commercial volumetric
modulated arc therapy (VMAT) units, which deliver the
dose to the whole volume during a single gantry rotation
(Otto 2008, Cao et al 2009, Webb and McQuaid 2009).
Current commercial units are the RapidArc® system (Varian
Medical Systems Inc., Palo Alto, Ca, USA) and Elekta VMAT
(Elekta AB, Stockholm, Sweden).
There are reports trying to quantify the respective
advantages of each system; see Beavis (2004) and Korreman
et al (2010) and, for more lively debates, see Bichay et al
(2008), Ling et al (2008), Bortfeld and Webb (2009), Ling
et al (2009), Mehta et al (2009), Mohan (2009), Otto (2009).
Be aware that it is sometimes difficult to separate commercial,
scientific and clinical arguments. Nowadays, technological
advances do not always render previous techniques obsolete,
and some competing solutions are still used simultaneously.
The advantages of the different techniques and models become
hard to quantify and it is not our place to seek epidemiological
proofs of the supremacy of any particular technique. We
refer the reader to better informed and more specialized
publications, and we will stay out of the many debates running
at the forefront of radiotherapy clinical results.
Some others in pursuit of the holy grail of radiotherapy
chose a different technological path. In the past, neutron
and ion radiotherapies were under development, but now,
proton therapy is a leading candidate among emerging
technologies. The localized energy deposition of protons
could be advantageous to achieve highly conformal dose
distributions and preserve healthy tissues (Brada et al
2007). Proton therapy still suffers from its very demanding
infrastructure and is currently limited to a few specialized
centres. Effort is currently being made to downsize the
accelerator and thus the size of the gantry.
We will try in the following paragraphs to summarize the
basic concepts of tomotherapy units as well as their implication
for users and remaining challenges. We will describe
some tomotherapy design particularities in comparison with
conventional LINACs. Sections are also focused on quality
assurance (QA), dosimetry procedures, radiation protection,
dose distribution and treatment planning.
2. Particularities of tomotherapy
The following paragraphs are meant to explicate some of the
particularities of tomotherapy. What we mean by particularity
is a characteristic which differs from a conventional LINAC.
We selected the particularities to discuss in an arbitrary fashion,
and it is not our goal to be exhaustive or highly detailed.
2.1. Design characteristics
Tomotherapy is essentially the result of merging an LINAC
and a CT in order to respond to the requirements of an ideal
radiotherapy treatment. Figure 2 shows the general concept
behind tomotherapy units. This particular heritage shows in
some of its design characteristics, while others stem from
choices of the development team.
The different components of the accelerator are visible
on the picture of an opened unit, figure 3. Tomotherapy dose
delivery to the patient is done helically, which is obtained by
simultaneously moving the couch and the gantry, figure 2. A
64-leaf binary collimator modulates a fan-shaped field during
3
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Figure 2. General principle of a tomotherapy unit.
Figure 3. Open TomoTherapy Hi-Art II.
Figure 4. TomoTherapy Hi-Art II multileaf collimator.
delivery, figure 4. The field’s maximum transverse dimension
is 40 cm, and three fan beam widths are commissioned by
the manufacturer, 1, 2.5 and 5 cm. The beam width, defined
by the y-jaw depicted in figure 2, forbids the conventional
reference beam size of 10 cm × 10 cm. The measure
of the displacement speed of the couch in relationship to
the gantry rotation speed and the field size is called the
pitch and is an important parameter influencing the dose
delivery.
Mackie et al (1993) described the ideas behind modern
tomotherapy. A moving slip-ring gantry used for radiotherapy
was introduced, which is essentially a standard CT gantry.
The tomotherapy gantry was then adapted from a commercial
HiSpeed gantry from General Electrics Medical (GEM), their
first industrial partner. The inner diameter of the gantry limits
the source-to-axis distance (SAD) at 85 cm, instead of the usual
100 cm in conventional accelerators.
Another design particularity of tomotherapy is that its
beam output is monitored in terms of absorbed dose per
unit time. In a conventional accelerator, the beam intensity
is monitored using units of dose per monitor unit. The
tomotherapy output monitoring is achieved using two ion
chambers located at the exit of the LINAC. The chambers
check if the dose rate remains in a defined window. At the
beginning of beam time, the output is known to be unstable,
which is why the MLC stays closed for the initial 10 s.
2.2. Beam characteristics
In LINACs as well as in x-ray tubes, incoming electrons
produce bremsstrahlung in a high atomic number target. In
a standard LINAC, the emitted photons go through a primary
collimator, where the beam is shaped, and, then, through a
flattening filter, where the beam fluence profile is flattened.
Some of the physical properties of the emerging photons
can be measured, but a complete description of the radiation
field is only obtained using Monte Carlo (MC) calculations.
Therefore, the description of tomotherapy beam characteristics
will draw from measurements and MC results.
The complete characterization of a tomotherapy beam
was first done by Jeraj et al (2004), and was later confirmed
using beam model studies for dose verification (Caprile and
Hartmann 2009, Sterpin et al 2010). It was reported that,
despite its design, the tomotherapy energy spectrum did
not significantly differ from a conventional LINAC with an
incident electron energy of 6 MV.
A very important aspect of tomotherapy design is the
absence of a flattening filter, which was already sketched
in 1993 by Mackie et al (1993). The unit is a dedicated
IMRT system and, therefore, does not need a flat dose profile.
Consequently, the beam fluence profile presents as cone-
shaped, where the intensity in the centre is twice as large
as on the sides, see figure 5. The lack of a flattening filter
results in a higher dose rate, which reduces treatment duration.
Higher dose rates can also be obtained in conventional
LINACs by optimizing the accelerator, for example the Varian
Trilogy (Varian Medical Systems Inc., Palo Alto, CA, USA).
Additionally, the lack of a flattening filter helps reduce the head
scatter radiation. Georg et al (2011) reported extensively on
the perspective offered by flattening free filter units.
The flattening filter of a conventional LINAC has a
strong contribution to the off-axis energy dependence of the
beam. Consequently, only little decreases in the beam energy
as a function of the angle are found. Jeraj et al (2004) reported
only a 5% energy decrease between the centre and the edge
of the tomotherapy beam, and the main effect was found
above 3 MeV.
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Figure 5. Typical beam fluence profiles in the longitudinal (left) and transverse (right) direction. The profiles were obtained experimentally
using an ionization chamber, and the beam conditions were 5 cm × 40 cm.
The tomotherapy system has two clinical modes, treatment
and imaging, which are obtained by varying the beam energy
to 6 MV and 3.5 MV, respectively. An additional physics mode
is implemented as well, which is reserved for the unit warm
up. The mean photon energy was found around 1.5 MeV for
the therapy mode and is reduced to 1.0 MeV during imaging
(Jeraj et al 2004). During imaging, the beam fluence is
significantly reduced to preserve the patient. The unit output
is consequently lowered by decreasing the incident electron
energy, by reducing the pulse frequency and by narrowing the
fan beam width to 4 mm.
2.3. Delivery characteristics
MLCs have greatly evolved since their introduction as a
replacement for shaping blocks. Nowadays, they are essential
to providing conformal radiotherapy. Tomotherapy uses a
64-leaf binary MLC to modulate delivery field as fast as every
20 ms, see figure 4. It has a typical interlocking tongue-and-
groove design in order to minimize leakage between leaves.
The beam is fan-shaped with a maximum transverse width
of 40 cm and adjustable slice thickness of up to 5 cm. The
thickness is defined by the opening size of the secondary
collimator (y-jaws in figure 2.), and a typical beam fluence
profile in the longitudinal direction is shown in figure 5. It
would even be possible to further increase the modulable
components of a tomotherapy unit by including a dynamic
secondary collimator (Mackie et al 1993, Gladwish et al 2004,
Sterpin et al 2010, Sterzing et al 2010), which might be
commercially available soon.
The configuration of a gantry that rotates around a moving
couch results in a helical delivery pattern, which is common
for CT, but unique in radiotherapy. A particular effect of the
helical delivery arises at the overlap between fluence profiles of
successive gantry laps. This effect has been studied by Kissick
et al (2005) and was named the thread effect.
The thread effect refers to a particular fluence pattern
noticeable on the delivery profile. It is a consequence of a
poor choice of pitch. When the pitch is too high, the delivery
profile of successive gantry laps will show some unevenness.
Therefore, the pitch has to be carefully selected in order to
avoid thread effects. Tomotherapy treatment parameters take
this effect into account, and in clinical use, a pitch of 0.287
is recommended. No studies on the clinical relevance of the
thread effect have yet been published.
A consequence of the helical mode is that the tomotherapy
delivery superimposes offset fluence profiles on a helical
trajectory. Any error along the couch axis will be repeated
for each treatment slice and will be magnified. This reality
necessitates maintaining strict QA requirements along the
longitudinal axis (Balog et al 2003).
2.4. Imaging characteristics
Since their first use in the 1970s, CT imaging techniques in
radiotherapy have become fairly standard. Historically, efforts
to improve treatment accuracy were first aimed at creating
better immobilization schemes and a generous coverage of
the target volume. The introduction of imaging capabilities
allowed radiotherapists to localize soft tissue structures more
precisely, and on-board imaging systems opened a realm
of new opportunities to optimize further delivery practices.
Nobody would argue that CT is the standard for treatment
planning, but on-board MVCT or CBCT provide adaptive
planning opportunities. Inter-fraction uncertainties can be
reduced, even when intra-fraction ones are still an issue
for most technologies (Verellen et al 2008, Martin and
Yartsev 2010). Various imaging systems have been tested
on LINACs, for example electronic portal imaging devices
(EPID), fluoroscopic imaging systems or ionization chambers,
all of which can provide anatomical information to improve
delivery accuracy (Keller et al 2002, Korreman et al 2010,
Mackie et al 2003).
Tomotherapy has a built-in on-board MVCT, and, as
previously explained, the LINAC beam fluence is decreased
purposefully for imaging purposes. An advantage of such
a configuration is that the imaging and treatment beams
are inherently aligned, which eases any required quality
5
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controls. Tomotherapy imaging detector is a standard CT
imaging system. An arc-shaped xenon detector is mounted
on the gantry opposite to the LINAC. The detecting volume
is composed of 640 submillimetre chambers separated by
tungsten plates. Only 520 chambers are used for imaging,
the standard image size is 512 × 512 pixels and the field of
view is 40 cm wide (Mackie et al 2003).
In the frame of the QA of the reconstruction system, Keller
et al (2002) studied the imaging characteristics of the detector.
They found that the detector is suited for megavoltage CT
imaging and image-guided radiotherapy, due to high efficiency
and adequate resolution. The dose delivered for imaging
purposes is consequently low, 10–30 mGy.
Another particularity of the mounting geometry is that the
detector is seated at 129.2 cm from the LINAC’s head but the
focal point of the arc-shaped detector is at 103.6 cm. This
off-focus geometry was found to further increase the detector
efficiency (Keller et al 2002).
2.5. Treatment planning
In radiotherapy, treatment planning involves the joint efforts
of medical and physics experts to plan the appropriate
geometric and radiological aspects of the therapy. Typically,
a representation of the patient, obtained using imaging
techniques, is used in a treatment planning system (TPS) to
determine various treatment parameters. An extract of typical
TPS dose distribution calculated for a tomotherapy unit is
shown in figure 6. It is a typical head and neck tomotherapy
treatment plan with concomitant boost. The prescribed doses
are 70 Gy, 59.4 Gy and 52.8 Gy for three target volumes.
A characteristic of tomotherapy resides in its TPS,
which uses an inverse planning dose calculation algorithm
of convolution and superposition (Mackie et al 1985, 1988,
Papanikolaou et al 1993). Briefly explained, the absorbed dose
to water is obtained by convolution of the energy deposition
kernel, which represents the relative energy deposited per
volume unit, and the total energy released per unit of mass
(TERMA).
The TPS calculates the delivered absorbed dose to water
using data obtained with MC calculations. The full delivery
is separated into single beamlets, which are defined as the
potential radiation delivered by a single leaf in a single
projection. They are calculated assuming 51 projections
per rotation, spanning 7.06◦ each, whereas the actual gantry
rotation on the machine is continuous. Each projection has
64 beamlets, which are directly related to the 64 leaves of the
MLC, and each beamlet is divided into multiple rays to ensure
at least one ray per voxel. The calculation takes into account
the specified field width, the dose calculation grid and the pitch.
The pitch has to be smaller than 1 in order to cover each slice
more than once. A smaller pitch allows more modulation, but
induces longer delivery durations. Therefore, a compromise
has to be found between the quality of the delivered dose,
quantified by the modulation possibilities, and the delivery
duration. As explained beforehand, the pitch must also be
carefully chosen in order to minimize the thread effect.
The TERMA is calculated by averaging the primary rays
which traverse the voxel volumes. The calculation uses a
Figure 6. Extract of a typical head and neck treatment plan with
concomitant boost. The prescribed doses are 70 Gy, 59.4 Gy and
52.8 Gy for three target volumes.
pre-computed fluence attenuation table (FAT), which gives
attenuation coefficient values in water (µw/ρ) and cortical
bone (µb/ρ) as a function of radiological depth. For interme-
diate densities, the attenuation coefficient is interpolated using
the values of water and cortical bone. For densities lower
than water, the calculations use the attenuation coefficient of
water, and for densities greater than cortical bone, the attenu-
ation coefficient of cortical bone is chosen. Beam hardening
is taken into account using the FAT calculated using poly-
energetic spectra. The spectral energy distribution is assumed
constant across the beam, which is a reasonable assumption
for accelerators without flattening filters (Jeraj et al 2004).
The polyenergetic deposition kernel is obtained by a
weighted sum of monoenergetic kernels, based on the spectral
energy distribution of the beam model. The convolution is then
performed using the collapsed cone approximation (Ahnesjo¨
1989).
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Figure 7. DVH of the treatment plan of figure 6. From left to right the curves are spinal cord, left parotid, right parotid, 52.8 Gy target
volume, 59.4 Gy target volume, 70 Gy target volume.
The helical mode of treatment requires representing the
MLC sequence for successive rotations, which is done using
a sinogram. It shows the succession of opening times for
each leaf at a given gantry angle during a given rotation.
The initial sinogram is dimensioned to match the volume
of the entire planning CT. An optimization of the sinogram
according to the treatment goals is achieved by iterative least-
squares minimization, which was described in detail by Olivera
et al (1998) and Shepard et al (2000). Another parameter
of the calculations is the modulation factor, which is defined
as the ratio between the maximum leaf open time and the
average leaf open time. A higher modulation factor allows
larger differences between respective beamlet weights, which
induces a better dose volume histogram (DVH). A typical DVH
obtained for a head and neck treatment is shown in figure 7.
However, the gantry speed needs to be low enough to
match the longest beamlet opening time in the plan. After all
optimization processes, full scatter calculations are performed
taking into consideration the requirements of the fractionation
schedule, the MLC, the couch and the gantry.
An interesting new approach to treatment parameter
optimization has recently been developed. This approach
is based on a non-voxel broad-beam (NVBB) framework
(Lu 2010). The evaluation of the optimization process is
generally done using an objective function, which quantifies
how good the optimized solution is. The evaluation of the
NVBB objective function is performed from a continuous
point of view. Thus, pre-calculation and storage of beamlets
are no longer needed. This framework can be implemented
in a single graphic processing unit (GPU) due to low CPU
requirements. This approach offers comparable dose accuracy,
but with a strongly reduced planning time in comparison with
the current TPS.
2.6. Dose distribution
Tomotherapy units are able to deliver high-quality conformal
treatment, and compared with static modalities deliver lower
doses to surrounding tissues, but these low doses are delivered
over larger volumes. As already stated, there is no current
consensus about the superiority of tomotherapy treatments
compared with a dynamic IMRT treatment such as VMAT
or RapidArc. There is abundant literature about treatment
planning comparisons between the different solutions, for
recent publication examples see Rao et al (2010), Marnitz et al
(2010), Wiezorek et al (2011), Mavroidis et al (2011), Murthy
et al (2011) or Zhou et al (2011), but the methodologies are
sometimes hard to compare. Up to now, clinical evidence of
the superiority of tomotherapy over other advanced treatment
techniques has not been demonstrated in randomized trials or in
prospective studies. Future clinical trials will have to compare
delivering lower doses over a larger volume with larger doses
over a smaller volume. This dose distribution raises concerns
about out-of-field doses and risks of radiation-induced second
cancers as well. It is our opinion that this matter should be
resolved by clinicians and epidemiologists in the not too distant
future.
2.7. Commissioning and QA
Procedures for accepting a new radiotherapy accelerator
are best conducted through the fruitful collaboration of the
company and the local medical physicist. Many IAEA
and AAPM documents review commissioning procedures for
each separate component of the treatment delivery system.
However, tomotherapy presents unique choices in terms of
hardware and treatment design, which have implications on
the initial commissioning process.
We will not illustrate the tomotherapy commissioning
procedure in detail, which is mostly analogous to a
conventional LINAC. Instead, we chose to emphasize two
particularities.
Due to the calculation algorithm, which is based on
convolution/superposition, the energy fluence spectrum and
magnitude should be quantified during commissioning. Due
7
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to its helical delivery mode, the procedure is special for
tomotherapy, and was described by Balog et al (2003).
Another tomotherapy particularity is that all planning
systems use a common beam model, which is known as the
gold standard, and is an average over the beam characteristics
of the first ten tomotherapy units. This implies that each
individual tomotherapy unit is adjusted to match the common
beam model within 1%. Therefore, it is essential to check that
the commissioned tomotherapy unit still matches the common
beam model implemented at the factory.
After collecting baseline data during the commissioning
procedure, a QA program will ensure the constancy of the
system. Early in the history of radiotherapy, QA systems were
introduced. They are based on defined test protocols having a
set frequency. QA systems are provided by recognized expert
groups (for example the AAPM or the IAEA).
The complexity of the new technology has to be matched
by the recommendations, which can result in a heavy work
load for the medical physicists. Also, recommendations have
a hard time keeping up with the rapidly evolving technology.
However, it is essential that the culture of QA remains a priority
within the radiotherapy community and, subsequently, the
support for study and introduction of new protocols (Van Dyk
2008, Thwaites and Verellen 2010).
Before any published recommendations, many authors
reported their QA procedures, some focusing more on specific
tools and others with a precise description of their routine
tomotherapy QA procedure (Fenwick et al 2004, 2005, Balog
et al 2006, Broggi et al 2008, Cherpak et al 2008, Flynn 2008,
Francois and Mazal 2009, Geurts et al 2009, Goddu et al 2009,
Burnet et al 2010, Zhou et al 2010). A consensus exists on
what to test but, sometimes, testing methods were different.
The AAPM recognized the challenges of tomotherapy, and
the particularities of the system, which recently inspired them
to make specific QA recommendations (Langen et al 2010).
The broader objectives of the mandated AAPM task group
were to propose QA procedures and dosimetry techniques. The
report of Task Group 148 of the AAPM (Langen et al 2010) set
QA requirements concerning delivery, imaging and treatment
planning. Some noteworthy goals of the tomotherapy QA
protocol are due to the complex mechanical design of the
rotating LINAC, which necessitates checking the mechanical
alignment of the LINAC with the primary collimator and with
the MLC. Synchronizing the couch movement with the gantry
is important, as well as verifying the gantry angles. Routine
checks of static and helical beam output are recommended.
Finally, the accuracy of the MVCT reconstructed images and
of the image registration procedure should be tested.
2.8. Radiation protection
Report no. 151 of the National Council on Radiation Protection
and Measurements (NCRP) describes guidelines for designing
structural shielding of a radiotherapy facility using x-rays
(NCRP 2005).
There are some specific issues related to room shielding
calculations for tomotherapy. The rotation of the gantry makes
the conventional usage factor obsolete, because it depends
Figure 8. TomoTherapy Hi-Art II dosimetric system ready for use.
on beam direction, and tomotherapy is a dedicated IMRT,
which significantly increases the workload factor. Shielding
considerations for tomotherapy were already discussed in 2000
by Robinson et al (2000). This first paper could not go into
much detail, because the unit design was not yet set, but the
primary issues were already clearly identified. Practically,
the LINAC should be carefully shielded first. Lead discs
and tungsten blocks are used around the accelerator head.
Moreover, the maximum longitudinal size of the beam is
5 cm, which reduces the primary shielding, which is achieved
using a 13 cm lead beam stop affixed to the gantry. Balog
et al (2005) performed measurements around a tomotherapy
unit and concluded that the scatter and primary radiations are
negligible in comparison with the level of leakage radiation.
They found the dose ratio of leakage to isocentre between
0.18% and 0.0006%. They provided the reader with some
typical calculations of the required wall thickness around the
facility. Their results were later confirmed by other studies
(Ramsey et al 2006, Kinhikar et al 2009). Practically, the
recommendations by Wu et al (2006) on how to install a
tomotherapy unit in an existing LINAC treatment room as well
as the analytical model developed by Baechler et al (2007) may
help future users to dimension their tomotherapy facility.
In conclusion, the AAPM generally recommends using
a conventional accelerator bunker for the installation of a
tomotherapy unit, but requires an extensive study in any case
(Langen et al 2010).
2.9. Dosimetry
To proceed with commissioning, QA and dosimetry,
tomotherapy units are delivered with a standard dosimetry
system comprising some ionization chambers and a phantom.
These tools are often cited in the literature concerning
tomotherapy.
A cylindrical Virtual Water™ phantom (Gammex Inc.,
Middleton, WI, USA) is supplied, which is often referred to
as the cheese phantom. It measures 30 cm diameter × 18 cm
length of Virtual Water™, can be opened in half to use
dosimetric films, and has lodgings for ionization chambers as
well as reference density inserts, see figure 8. Virtual Water
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Sensitive volume
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Outer electrode
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Figure 9. Basic design of an ionization chamber.
is a type of synthetic material, which mimics the attenuation
and diffusion behaviour of water in a defined energy range. It
is routinely used as an alternative to water tanks, which can be
cumbersome to use.
Three types of chambers are provided as well. The
reference ionization chamber is the Exradin A1SL ionization
chamber (Standard Imaging, Middleton, WI, USA) with a
collecting volume of 0.057 cm3. A Farmer-type chamber is
available, the A12S (Standard Imaging, Middleton, WI, USA),
but many users will already have a Farmer-type chamber on
hand. A microchamber with a collecting volume of 0.016 cm3,
the A14SL (Standard Imaging, Middleton, WI, USA), is
sometimes provided for small field dosimetry. Finally a CT
type chamber, the A17 (Standard Imaging, Middleton, WI,
USA), with a collecting volume of 1.91 cm3, is used with the
MVCT. The chambers are coupled to an electrometer called a
Tomoelectrometer (Standard Imaging, Middleton, WI, USA).
The calibration coefficients of the chambers are traceable to
the American National Metrology Institute (NIST) in absorbed
dose to water only for the beam quality of Co-60.
Figure 9 illustrates the basic design of ionization
chambers. An ionization chamber’s response depends on
its geometry. Typically, the chamber sensitive volume
can differ as well as its shape and size. The electrical
properties of the electrometer, which measures the ionization
current, is important as well. Gas-filled ionization chambers
have been the gold standard in dosimetry until now.
Recently, some practical limitations are becoming clear,
for instance, the relatively large chamber size alters its
response when measuring small fields, high dose gradients, and
inhomogeneous fluence distributions. Of particular interest
for small radiation fields is that the beam size is smaller
than the range of secondary charged particles, which prevents
charged particle equilibrium (CPE) from happening. CPE is
a necessary condition for using cavity theory, which underlies
measurements performed with ionization chambers. When
CPE conditions are reached, the dose in a medium can be
deduced from the dose in the air by applying a correction
factor obtained by the stopping power ratios of the medium
to air. In a small field, the presence of a detector can change
the trajectories of the charged particles locally (Attix 1986,
Gray 1929, 1936). Measuring time-dependent fluences is
a challenge as well. MC calculations are recognized as a
valuable tool, where measurements are not easily feasible.
Using MC calculations validated experimentally, correction
factors tailored for specific machines and detectors can be
obtained and will be essential for the tomotherapy absolute
dosimetry and treatment planning (Das et al 2008, Caprile and
Hartmann 2009, Sterpin et al 2010).
Similarly to QA protocols, dosimetry recommendations
are provided by recognized expert groups (AAPM or IAEA),
but to this day, there is no such reference for the evaluation
of the absolute dose of a tomotherapy unit. The need
for a new international code of conduct for small radiation
field radiotherapy is clear, because the conventional reference
conditions are no longer adequate when applied to tomotherapy
and other technologies, such as the RapidArc® system (Varian
Medical Systems Inc., Palo Alto, CA, USA), VMAT and
Leksell Gamma Knife® (Elekta AB, Stockholm, Sweden),
Cyberknife® (Accuray Inc., Sunnyvale, CA, USA) and
Vero Stereotactic Body Radiotherapy (SBRT) (Brainlab AG,
Feldkirchen, Germany, and Mitsubishi Heavy Industries Ltd,
Tokyo, Japan).
The absorbed dose output calibration of a conventional
accelerator is described in the IAEA TRS-398 code of practice
(Andreo et al 2000) and in the AAPM’s TG-51 protocol
(Almond et al 1999). The documents base an accelerator’s
absolute dosimetry on the use of an ion chamber, but mostly
differ in the definition of the radiation beam quality. An
adequate formalism for the dosimetry of small and composite
fields was developed in order to extend the existing protocols
(Alfonso et al 2008). Alfonso et al (2008) provide a
framework for establishing a standard dosimetry applicable to
a wide variety of technology. New parameters accounting for
particular reference conditions as well as treatment modes were
introduced. Some measurements and calculations tailored for
tomotherapy were performed by Jeraj et al (2005), Thomas
et al (2005), Xiong and Rogers (2008), Bailat et al (2009),
Francois and Mazal (2009), Kragl et al (2009), Sauer (2009),
Ceberg et al (2010), Palmans et al (2010). These studies can
be used to obtain some of the parameters as well as correction
factors to perform absolute dosimetry measurements.
The issue of beam size is not unique to tomotherapy, and
manufacturers offer a variety of technical solutions. A non-
exhaustive list comprises small volume ionization chambers,
diode detectors, diamond detectors, MOSFET dosimeters,
optically stimulated luminescent and thermoluminescent
dosimeters, alanine dosimeters and films. The chosen
technique will have to answer the requirements of the small
field size as well as stringent metrological ones. However
promising some technologies are, the weapon of choice
remains the ionization chamber, and much effort is made to
extend the methodology instead of changing technology.
Another challenge of tomotherapy is the helical treatment
mode. The formalism introduced by Alfonso et al (2008)
clearly recognizes the necessity of evaluating the helical dose
delivery. The National Physical Laboratory in the UK (NPL)
designed a methodology to provide reference dosimetry for
Co-60, gamma-ray and megavoltage photon beams using
alanine dosimeters (Duane et al 2006a, 2006b). This IMRT
auditing system is mainly tailored for tomotherapy units. A
Rexolite™ phantom enables the simultaneous irradiation of
alanine dosimeters and ionization chambers. Dosimetry using
alanine is used routinely as a secondary standard by national
metrology institutes. Alanine dosimeters are water-equivalent,
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can be located in a small volume, and show no strong energy
dependence in the MV range. Alanine dosimeters coupled with
electron spin resonance reading have uncertainties compatible
with the requirement of absolute dosimetry procedures and are
independent of many assumptions made to interpret ionization
chamber results and provide an independent confirmation or
chamber calibration (Anton 2006, Bailat et al 2009).
3. Future opportunities
Already in the original paper describing tomotherapy as well
as in a review paper about IGRT (Mackie et al 1993, 2003), the
development team identified potential opportunities for dose
optimizations using MVCT data. Tomotherapy dose delivery
is mathematically similar to tomographic imaging, and back-
projection reconstruction algorithms can then be implemented
for dose optimization. As a result, the obtained dosimetric data
could be used in conjunction with a patient’s treatment plan to
tailor it for the next session.
The future usage of the MVCT data is central to several
issues affecting dosimetric developments, but currently the
MVCT data are only used for patient positioning. In the
future, these images could be used to assess the actual dose
delivered during a session knowing the patient’s anatomy
and to recalculate the treatment plan taking into account the
patient anatomy of the day as well. The imaging system
will have to be very stable in order to obtain usable MVCT
images. Many studies have been published investigating
the challenges and requirements of dose reconstruction using
MVCT data (Kapatoes et al 2001a, 2001b, Langen et al 2005,
Schombourg et al 2009, Duchateau et al 2010, Zhou et al
2010). In practice, the tomotherapy planning system uses
Hounsfield units expressed in terms of mass density, instead
of the conventional relative electron density. Therefore, in
order to use MVCT images for dose evaluation, they have to
be calibrated in terms of mass density. This calibration is
performed using a cylindrical phantom with inserted reference
density objects. A table of correspondence called an image
value-to-density calibration table (IVDT) is then obtained. In
order to use MVCT for daily patient dose evaluation, an IVDT
will have to be obtained for each patient, which remains a
practical problem.
Also, adaptive radiotherapy could be performed using a
daily reconstructed dose distribution. The implementation of
this technique still necessitates some studies as well as software
development, and a commercial solution would be an exciting
development. This new foreseen development will reduce
inter-fraction uncertainties, but changes happening during the
treatment fraction will remain a challenge (Verellen et al 2008,
Martin and Yartsev 2010).
4. Conclusions
The ultimate cancer treatment would be able to kill all
malignant tissues while preserving healthy ones. Currently,
radiotherapy is one of the standard tools of radio oncologists,
and it strives to reach the lowest toxicity possible. Since
the time of the first medical LINACs in the 1950s, many
developments worldwide made LINACs the radiotherapy
instruments of choice over van de Graafs, betatrons and Co-60
irradiators. At the turn of the new millennium, radiotherapy
gave birth to IMRT. The treatment zone is now defined by
the intersection of numerous beamlets, which allows highly
conformal irradiation volumes. A current IMRT system
is the TomoTherapy® Hi-Art® accelerators (Tomotherapy
Inc., Madison, WI, USA), which began its life in the minds
of scientists at the University of Wisconsin in the 1980s.
Conceptually, the innovative idea behind tomotherapy units
is to marry a CT unit with an LINAC. The obvious goal
was to deliver beamlets from all radial directions around the
patient and achieve a highly conformal dose distribution. Some
competing IMRT units are IMATs, such as the RapidArc®
system (Varian Medical Systems Inc., Palo Alto, CA, USA)
and Elekta’s VMAT (Elekta AB, Stockholm, Sweden).
The dose distribution delivered using a tomotherapy unit is
indeed highly conformal, and compared with static modalities
it delivers lower doses to surrounding tissues. However, the
superiority of tomotherapy over other modalities remains to
be clinically proven. Additionally, low doses are delivered
over larger volumes compared with static modalities. Clinical
studies will have to investigate the effects of delivering lower
doses over larger volumes in comparison with delivering larger
doses over smaller volumes.
Although the highly conformal treatment delivery is
noteworthy, the use of on-board MVCT could lead to
interesting progress as well. Effectively, images of a patient
could be taken prior to the radiotherapy session and an
evaluation of the treatment plan using the planning CT images
could be performed. Furthermore, a reconstruction of the
delivered dose could be performed afterwards and could enable
the accurate correction of any patient inter-fraction variations.
In the future, such technologies may allow simultaneous
imaging and treatment, and therefore correct inter- and intra-
fraction variations.
In conclusion, TomoTherapy® Hi-Art™ is a promising
system which meets some of the needs of the medical physicist
community. Other manufacturers offer their own IMRT
solution and the competition is fierce. The clinical results are
still accumulating and epidemiological evaluations will help
direct clinical choices in the future.
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